Connect with us

All about Cannabis

Ten Reasons to Ignore the FDA and Try CBD – Cannabis | Weed | Marijuana



There are at least ten reasons to ignore the FDA and try CBD.

The U.S. Food and Drug Administration published a study this week suggesting that long-term use of CBD leads to liver toxicity and reproductive issues in males and females.

They used animal studies to support their conclusions.

But what about studies done on human beings showing CBD’s benefits? Here are ten reasons to ignore the biased FDA and try non-toxic CBD.

Ten Reasons to Ignore the FDA and Try CBD

10. CBD Can Solve the Opioid Crisis

COVID-19: Vancouver's Downtown Eastside - a potential powder keg for coronavirus cases

A study published in 2019 found CBD reduced cravings and anxiety related to heroin withdrawals. This study was a randomized, double-blind, placebo-controlled trial involving 42 people.

Want to solve the opioid crisis? Instead of handing out weak opioids that addicts turn around and sell for fentanyl, hand out CBD.

Make CBD so plentiful that it too will drop to 25 cents for an 8mg capsule.

9. CBD Blocks Covid

We’ve covered this before. While it’s not conclusive, it’s certainly promising. No wonder the FDA wants the public to link “CBD” with “toxicity.” The powers that be profited immensely from covid hysteria.

The last thing they want is a non-toxic, all-natural cure—another reason to ignore the FDA and try CBD.

8. CBD Reduces Anxiety 

Ignore FDA Try CBD

The mental health cottage industry generates billions every year. Pharma doles out a cocktail of anti-anxiety meds that doctors prescribe like candy, all with side effects that are sometimes worse than anxiety.

But once again, we can ignore the FDA and try CBD knowing full well that the science is on our side. A randomized, double-blind, placebo-controlled trial demonstrated how CBD reduces social anxiety disorder, the most common form of anxiety. 

Of course, like the heroin withdrawal example, the participants took up to 400mg of CBD daily. To make these doses affordable, governments everywhere must open their cannabis markets and allow for unrestricted trade.

No more licenses or special regulations. Cannabis is a vegetable that belongs at your local farmers’ market.

Ten Reasons to Ignore the FDA and Try CBD

7. CBD Protects the Immune System

Ignore FDA Try CBD

Using data from animal studies, the FDA concludes that CBD harms the immune system and makes it less effective in fighting cancer.

No other studies find this.

Most studies find that CBD stimulates the uptake of hormones that support the immune system. Specifically, CBD increases the activity of TRPV2 receptors which makes communications between cells more effective.

(Sidebar: isn’t it interesting that Ivermectin was called “horse dewormer” by the corporate press despite some of its success in combating covid in human beings? But to prove CBD is toxic, the FDA has to throw out every study on people and relies on data solely from animals).

6. CBD is an Anti-inflammatory

Being anti-inflammatory is one of the significant benefits of CBD. It’s also one of its most well-known effects. Inflammation, of course, is an immune system response. So once again, the FDA’s claims are questionable.

Chronic inflammation can weaken the immune system, hence why CBD is sought after by many with autoimmune issues.

5. CBD Reduces Oxidative Stress

Ignore FDA Try CBD

Reducing oxidative stress is related to CBD’s role in reducing inflammation. But it’s worth noting since the FDA study suggested the opposite.

Of course, this 2020 review of the literature found that “multidirectional biological effects have been demonstrated in various preclinical models, including the antioxidant and anti-inflammatory effects of cannabidiol.”

And to be fair to the FDA, this review also found that “CBD may interfere with the hepatic metabolism of some drugs by inactivating cytochrome P450 3A and P450 2C.”

In other words: if you’re taking drugs metabolized by the liver, check with a doctor before mixing in CBD.

Ten Reasons to Ignore the FDA and Try CBD

4. CBD Reduces Pain 

people choose cannabis for chronic pain

Ignore the FDA and try CBD. If you’re experiencing chronic pain, that’s your best bet. Even if the FDA’s study is 100% accurate and that long-term CBD use is toxic – that might be a worthwhile trade-off.

Everybody knows alcohol wreaks havoc on the liver. But that doesn’t stop people from binge drinking.

Likewise, if it’s true that CBD will wreck your liver in the long term, is that not an appropriate trade-off for those experiencing chronic pain?

The studies show a THC-CBD combo work best.

So who is the FDA to tell suffering Americans that they shouldn’t try this natural herb because, maybe, potentially, just possibly, according to animal studies, it might cause liver toxicity in the long run? 

Whether the pain is chronic or acute, I’ll take my chances.

3. CBD Reduces Seizures

Ignore FDA Try CBD

If you have a child with epilepsy, will you fret over some long-term possibility that the liver may get damaged? Or are you looking for an immediate solution?

CBD’s ability to reduce and even eliminate seizures in children warrants its legalization and mainstream acceptance. Full stop.

Of course, the FDA has already approved a CBD-derived drug. Epidiolex is a patented CBD-derived pharmaceutical designed to treat epilepsy.

In other words, the cannabis plant alone isn’t enough. We need capital-intensive pharmaceutical companies to extract the cannabinoids and package them into a manufactured drug the FDA can approve.

Only then will these liver toxicity concerns disappear. 

2. CBD Aids Sleep

According to the CDC, more than a third of American adults aren’t getting enough sleep. CBD helps with that. So once again, we can ignore the FDA and try CBD. 

Even if the FDA’s claims are all true (a low probability, but let’s throw them a bone), liver toxicity in old age will be the least of your concerns. 

If you’ve spent the last few decades suffering from chronic insomnia, the same long-term effects as alcohol consumption shouldn’t phase you.

Sleep is crucial to maintaining good health.

Ten Reasons to Ignore the FDA and Try CBD

1. The FDA is Biased & Useless

Ignore FDA Try CBD
Who regulates the regulators?

The number one reason Americans can (and should) ignore the FDA and try CBD is because the FDA is biased.

And with over half of their funding coming from the pharmaceutical companies they’re supposed to be regulating – the FDA is useless, too.

The FDA has long supported cannabis’ classification as a Schedule 1 drug. Meaning it has no therapeutic or medicinal value.

How far does your head have to be up your ass to believe such nonsense?

What about FDA enforcement? Surely, the section of the bureaucracy not funded by big pharma protects Americans from fraudulent claims made by drug manufacturers.

No, the FDA has not addressed the lies, fraud and propaganda about the covid vaccines.

But suggest that cannabis helps with cancer? Or, as per scientific inquiry, that it has the potential to block a covid infections?

The FDA will have nothing but time and attention for you. The FDA has one purpose and one purpose only: gatekeeping.

Protect the pharma cartel and ensure Americans don’t get too independently healthy. Health comes from a patented pill, not your diet or natural plant compounds.

Like its northern neighbor Canada, U.S. health regulators are increasingly funded by the people they’re supposed to regulate.

In what world does that make sense? The FDA is not a private accreditation company. Cannabis companies can’t ignore them. 

But Americans can ignore the FDA and try CBD. And it’s high time they do. It’s time to rein in the excess bureaucracies choking the once-free and prosperous union.

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

All about Cannabis

Basic Cannabis Economics – Cannabis | Weed | Marijuana




Basic cannabis economics. Wherever you find reefer madness, a poor grasp of basic cannabis economics is right behind it.

For example, public health busybodies demand THC limits. As if adults choosing high-THC strains of cannabis will simply shift their demand to lower-THC strains once public health tells them what their preferences should be.

Most, if not all, government workers lack an understanding of basic economics and, therefore, basic cannabis economics.

So let’s clear up some misconceptions. First, let’s start with a definition from economist Thomas Sowell.

“The first lesson of economics is scarcity: There is never enough of anything to satisfy all those who want it. The first lesson of politics is to disregard the first lesson of economics.”

Politicians Who Don’t Understand Basic Cannabis Economics

Basic Cannabis Economics

Canadian Prime Minister Justin Trudeau legalized cannabis in 2018, three years after pledging to do so.

From the beginning, we covered what Justin Trudeau meant by legalization (i.e. Corporatization) and what he should do instead (remove cannabis from the criminal code and rely on our common law/customary traditions for regulation).

But Justin Trudeau does not understand basic economics, including basic cannabis economics.

The trust-fund prime minister believes federal budgets balance themselves. That economies grow “from the heart outwards,” which must be doublespeak for running up the credit card.

The former drama teacher also thinks inflation isn’t a concern for “families,” which he claims to care about.

Justin Trudeau is a textbook example of a politician that places “compassion” and what sounds good over what works. He is the type of politician that ignores scarcity.

But the problem isn’t only in Canada.

Basic Cannabis Economics

Connecticut, for example, is trying to enforce THC limits unsuccessfully. Retailers can’t sell flower higher than 30% THC; concentrates are capped at 60%.

But convenience stores, gas stations, and CBD-only stores can get around these limits by focusing on delta-8 THC.

Obviously, a politician with an understanding of basic cannabis economics would declare THC limits a failure. They would find another way to persuade people to consume lower-THC cannabis. Maybe by trying a method based on consent rather than coercion.

But Democratic Representative Mike D’Agostino thinks the problem is that the rules aren’t strict enough. As he told the House, 

All we’re trying to do is make sure that any products that are sold with a significant amount of THC in Connecticut are sold in our regulated marketplace through the dispensaries, where there’s labeling requirements, there’s per package requirements, there’s per container requirements.

And all Fidel Castro was trying to do was create a “new socialist man” who would set aside all personal interests, goals, and desires to devote his life to building a communist society.

It may look like a stretch to compare THC limits to systemically dismantling the market economy for a utopian ideal, but the principles are the same.

Politicians who don’t understand basic cannabis economics will destroy the cannabis industry before it can thrive. 

Look at Canada’s cannabis sector. Even large producers struggle to keep up with the government’s criminal excise tax structure.

Politicians who don’t understand basic cannabis economics are the biggest threat to cannabis legalization. The world can now look at Canada and conclude, “I guess cannabis legalization doesn’t work.”

Basic Cannabis Economics in the Edible Market 

Basic Cannabis Economics

Economics studies cause and effect, showing what happens when you do specific things in specific ways. With basic cannabis economics, we should look at the incentives certain decisions create rather than the stated goals.

In other words, consequences matter more than intentions.

Canada’s public health busybodies say because children are attracted to cannabis edibles, THC limits and other restrictions are justified.

It’s easy to declare good intentions and blame others for the problems. But, by understanding basic cannabis economics, you can see how Health Canada‘s strict edible rules have led to counterproductive, even disastrous, consequences.

The Canadian government hasn’t changed consumer demand. People still want potent edibles. The consequences have been

  • a) continued revenue streams for “illicit” edible makers and;
  • b) legal producers are focusing on potent cannabis extracts.

Health Canada sees the consequences of their actions but refuses to take responsibility because they don’t understand basic cannabis economics.

They released a statement decrying “copycat” cannabis edibles, especially since they appeal to children. (Ignoring that refined sugar is generally terrible for children or that teens are experimenting with “safe supply” opioids in B.C. An issue much more severe than illegal cannabis edibles).

And instead of acknowledging that THC limits are counterproductive, they go after potent extracts they consider “edibles.”

Health Canada may argue that child-resistant packaging and THC limits are necessary “for the children.” But, at the same time, they complain that legalization and “privately-owned for-profit” dispensaries have resulted in higher hospitalizations and E.R. visits by children who have accidentally consumed cannabis edibles.

So which is it?

Basic Cannabis Economics 

Basic Cannabis Economics

Many people think economics involves money, finance, and banking. And it does. But at its core, economics, including basic cannabis economics, is about the logic of action.

Consider a clean-up crew arriving after a cannabis festival. Maybe the garbage cans are piled high. Cannabis roaches and lost paraphernalia litter the ground. The clean-up crew is confronted with an economic problem.

Where to start? They must allocate their scarce resources (cleaning supplies and equipment), which have alternative uses. Do they start with the bathrooms or by emptying the garbage cans?

Perhaps a discarded joint starts a small bushfire. The clean-up crew would be wise to begin there.

Human life consists of allocating time and resources efficiently. This is an inescapable fact of reality. 

In this example, no money has changed hands, and there’s no market in the traditional sense. But the choices made by the clean-up crew are necessarily economic.

There are no solutions. There are only trade-offs.

Yes, public health can limit THC and demand child-resistant plain packaging. But the trade-off incentivizes others to produce high-THC edibles in packaging that are pleasant to the eye.

Why must ‘copycat’ cannabis edible appeal to children? Are adults not allowed to enjoy the marketing of their favourite chips, candy, and chocolate brands?

Making choices is at the heart of economics. Understanding basic cannabis economics means understanding that you can’t change people’s preferences by affecting supply.

All you do is frustrate consumers and incentive black markets. It’s not like public health is trying to keep the public from consuming tide pods or inhaling aerosols.

In fact, if they took the heavy-handed approach to those issues as they did with cannabis, they would lobby for the prohibition of those goods. 

Which would create a black market (or at least incentivize alternatives, like the popularity of synthetic cannabis in places with strict cannabis prohibition).

Public Health is a Joke

Public health busybodies wonder why some people don’t listen to them.

Imagine going to the doctor, and he gives you financial advice. It may be sound financial advice, but it’s not their place to provide it. Not in that setting.

Likewise, I expect medical professionals to take a cautious, conservative approach to high-THC cannabis edibles. They have every reason as “public health” to provide prudent insights and opinions.

But enforcing these opinions through government laws is one step too far. It ignores basic cannabis economics and reduces individual adults to an infantile state.

It also doesn’t work.

Source link

Continue Reading

All about Cannabis

Cannabis Sending Pregnant Women to Hospital: Study – Cannabis | Weed | Marijuana




Cannabis is sending twice as many pregnant “people” to the hospital, says a new study on cannabis use during pregnancy published in the Canadian Medical Association Journal.

(And yes, the study calls pregnant women “people” in an attempt to be “inclusive” by insulting women and rejecting biological facts.)

The researchers looked at over 950,000 pregnancies between January 2015 and July 2021. They found the rate of ER and hospital visits related to cannabis use during pregnancy doubled.

Ergo, legalization has failed Canada’s pregnant “people.”

Of course, doubling the rate sounds bad until you ask what the baseline is. Before legalization, for every 100,000 pregnancies, hospitals saw 11 women seeking care for consuming too much cannabis.

After legalization? It’s 20 women per 100,000. And as per the study, these women were “very high” and thus seeking help.

In other words: the reefer madness hysteria drummed up by this study is not justified.

Cannabis Sending Pregnant Women to Hospital: Study

cannabis pregnant cannabis use during pregnancy

As per the research, pregnant “people” have “cannabis use disorder” and thus cannot control or stop their use even when they’re pregnant. They came to this conclusion because 22 percent experienced withdrawals.

But how does one casually link physical withdrawals of a substance to physiological dependency? They are two different processes. One is the physical state of the brain and body excreting a drug; the other is the subjective experience of that phenomenon.

The study suggests that “cannabis use during pregnancy is associated with adverse perinatal and neonatal outcomes, including stillbirth, preterm birth and neonatal morbidity and mortality.”

Additionally, they cite “evidence” of an association between cannabis use during pregnancy and autism. But the study they refer to emphasizes a “cautious interpretation” due to confounding factors.

Likewise, the other studies they refer to rely on self-reported cannabis use. One of them doesn’t even support the conclusions they claim it does.

Consider one of the papers they cite: “Maternal marijuana use, adverse pregnancy outcomes, and neonatal morbidity.”

It says, “After adjustment for tobacco, clinical, and socioeconomic factors, marijuana use was not associated with the composite adverse pregnancy outcome.”

It goes on to say,

Similarly, among women with umbilical cord homogenate and serum cotinine data (n = 765), marijuana use was not associated with adverse pregnancy outcomes (adjusted odds ratio, 1.02; 95% confidence interval, 0.18–5.66). Neonatal intensive care unit admission rates were not statistically different between groups (16.9% users vs 9.5% nonusers, P = .12).

They admit that “marijuana use was still associated with composite neonatal morbidity or death,” but only after controlling for “tobacco, race, and other illicit drug use.”

How cannabis use during pregnancy differs between ethnic groups remains to be seen.

As well as adjusting the results not to include tobacco damage is also suspect. Especially when both cannabis and tobacco use were self-reported.

Methodological Problems with the Study

As always, researchers love to use specific tools that will provide the results they expect. This study is no different from many studies that paint cannabis as a toxic substance.

Here are the issues with the study saying cannabis is sending pregnant women to the hospital:

  1. It’s an observational study. Researchers cannot establish casualty. The other paper referenced (linking cannabis to autism) was aware of this limitation. This recent study ignores the problem and cites observational research as scientific evidence.
  2. This study relies on Ontario, Canada’s population of pregnant “people.” While it’s safe to assume what is true for Ontario‘s pregnant women is true in, say, Montana, the specific population sample limits the generality of the findings.
  3. As mentioned, the data in this study and the others rely on self-reporting. What kind of cannabis did the women consume? Sativa? Indica? Low-THC high-CBD strains? How strong was it? What was the terpene profile like? What were the primary delivery methods? What about other non-cannabis-related hospital visits? Maybe these 20 women out of 100,000 would also visit an ER for a bruise or scrape. What was the mental health of these women like?
  4. The paper mentions using multivariable logistic regression models to identify cannabis and pregnancy risk factors. But the researchers don’t provide details on these models, including the variables used or how they measured them.
  5. This paper focuses on acute care visits related to cannabis, comparing it to acute care visits for non-cannabis substance use as a control. But the researcher’s choice of control introduces biases. Cannabis and other “non-cannabis substances” can’t be compared.

Cannabis Sending Pregnant Women to Hospital: Study

cannabis pregnant cannabis use during pregnancy

Should you use cannabis for morning sickness? That’s a question for you and your doctor. Whether cannabis use during pregnancy causes problems, including stillbirth, the jury is still out.

Toronto Star article on this study interviewed a range of doctors who said cannabis use during pregnancy was a bad idea. They also insultingly referred to pregnant women as “pregnant people.”

But at the end of the article, buried at the bottom, was one doctor, Dr. Lisa Graves, who dared speak the truth.

She said there is too little research on cannabis use during pregnancy.

Of course, “cannabis use” is not a thing. I don’t “use caffeine.” I have a cup of coffee. Sometimes I have two or three. Rarely do I have a fourth.

Likewise, when my sister-in-law was pregnant, her doctor said, “One cup of coffee a day is fine.” Apparently, too much coffee is bad for an unborn child.

And it could be that too much cannabis is harmful to them as well. It could be that in the future, more rigorous studies find that more than 10mg of THC daily is detrimental to healthy development.

The problem is we don’t have any conclusive studies on the topic. Is cannabis sending pregnant women to the hospital? No, women are sending themselves to the hospital. 

Their cannabis consumption use may be the reason for the visit. But this study tells us very little (if anything) beyond that. 

Source link

Continue Reading

All about Cannabis

Three Signs of Reduced Cannabis Stigma – Cannabis | Weed | Marijuana




What are three signs of reduced cannabis stigma? Don’t get us wrong – cannabis stigma is still alive and well. But in the past week, we’ve encountered three new stories that indicate the needle is moving in the right direction.

From British Columbia declaring that cannabis retail shops don’t have to cover their windows to Switzerland expanding their legal cannabis pilot. Progress may be coming at a snail’s pace, but it’s something.

What is Cannabis Stigma?

We can’t identify reduced cannabis stigma without asking: what is cannabis stigma? What is stigma?

Earlier this year, Dr. Julian Somers told CLN that stigma was like a scarlet letter. “There’s a sign about you,” he said. “Maybe you sound less formally educated or you look like you’re a little undernourished, maybe you’ve got some piercings and ink on your neck or something. Things like that.”

While Dr. Somers was speaking in context to the drug and homelessness problem in all major Canadian cities, you could say the same for cannabis stigma.

Indeed, there’s a stigma associated with reggae music, bongs, Cheech and Chong, and other 20th-century stereotypes about cannabis consumers.

Non-cannabis users tend to view cannabis consumers as more dopey or less intelligent than the more “sophisticated” types that prefer to drink cocktails after work.

There’s a stigma associated with smell: too many medical cannabis patients have been victims of this. Especially during those “sobriety checkpoints” the police like to set up.

There certainly wasn’t any reduced cannabis stigma when Canada legalized cannabis. If anything, cops and public health busybodies amped up the drug war propaganda to eleven.

#3 Reduced Cannabis Stigma: Window Coverings 

reduced cannabis stigma

A significant cannabis stigma in Canada is window coverings. Despite cannabis being legal and hidden behind opaque plastic child-resistant containers – governments demand retailers wrap their windows so no one can see in.

After a series of robberies and break-ins, the British Columbia government finally agreed with cannabis retailers. These opaque window wrappings are more harmful than helpful.

The most obvious example is a robbery in Vancouver earlier this year. Security footage showed the criminal trying to steal from the shop.

Typically, if you try to rob a store in broad daylight, people walking by are witnesses and can call for help. But with opaque window coverings?

Who knows what’s going on in there?

Notably, B.C.’s many public and private liquor stores don’t require window coverings.

#2 Reduced Cannabis Stigma: Switzerland Expanding Cannabis Trials to More Cities

cannabis in Switzerland

Ideally, Switzerland would legalize cannabis completely. If someone is fining you or sticking you in a cell for a nontoxic herbal plant, then that person is the criminal.

Statute law by governments is not the be-all, end-all of what’s right and wrong. You’d think this point would be well-known. But decades of government schooling and the erosion of religious values have us lost in the wilderness.

Regardless, Switzerland’s move to expand its strictly-controlled cannabis industry is toward reduced cannabis stigma.

Long-term, this may prove more advantageous. While many U.S. jurisdictions legalize in a manner more consistent with the values of individual liberty and private property – Switzerland’s top-down approach comes with one significant benefit.

The Swiss’s cannabis trials are decentralized and conducted by different universities. Multiple research findings will root out bias and narrow in on objective observations found in all studies.

In other words: cannabis legalization in Switzerland is a product of multiple researchers in different cities rather than bureaucrats implementing a one-size-fits-all regime based on their definition of “best practices.”

While legalizing in this way still indicates that cannabis stigma is alive and well – just the fact that the Swiss have embarked on this program (followed by the Netherlands and a non-profit German model) shows that reduced cannabis stigma is becoming the norm.

#1 Reduced Cannabis Stigma: Doctors Aren’t Drinking the Koolaid

reduced cannabis stigma

Last week, researchers published a study indicating that “cannabis use disorder” causes schizophrenia. Many in the media repeated this study’s findings without referencing its numerous methodological problems.

We covered it here, but you might be skeptical that a site calling itself “Cannabis Life Network” would give an unbiased account.

So here’s an article from an actual M.D. He, too, comes to the same conclusion.

The study says, “Assuming causality, approximately 15% of recent cases of schizophrenia among males in 2021 would have been prevented in the absence of CUD [cannabis use disorder].”

But as Dr. Chuck Dinerstein wrote: 

“I am not ready to make that leap. There is more science to consider. I am willing to consider cannabis, and for that matter, alcohol gateways to mental disease, but I believe it may be more critical to recognize that the gate swings both ways – that is, schizophrenia, in this instance, is a gateway to substance abuse…The narrative can go in either direction.”

Can cannabis trigger schizophrenia in individuals predisposed to the disease? Yes, all research indicates that. The same is true for any substance, and alcohol looks to be the worst of them all.

Is 15% of schizophrenia due to cannabis?

But will cannabis cause schizophrenia in otherwise healthy young, adult males? “Not likely,” says Dr. Dinerstein.

And for us, that is the number one sign of reduced cannabis stigma. With cannabis legalization becoming a force that governments and pharma lobbyists can’t stop, they are increasing anti-cannabis propaganda to protect their investments.

Like giving children hormone blockers (or homeless addicts free opioids, or criticizing the covid regime), many doctors are too afraid to speak out. We’ve returned to the pre-Christian values of public humiliation.

So for an actual M.D. to read this Danish study and publicly declare that the researchers made “a leap of faith” in connecting cannabis use and schizophrenia is a breath of fresh air.

It’s a sign of reduced cannabis stigma.

The Future of Cannabis

reduced cannabis stigma

We’re not out of the woods yet. Cannabis stigma is alive and well. But these three recent stories indicate that trends are moving in positive directions.

Public health can complain and cry like children all they want. The fact is: people are ditching their meds and alcoholic drinks for cannabinoid therapy. 

Treating cannabis retail like a Great Depression-era bookstore selling “Tijuana bibles” is coming to an end. Even the most conservative European countries (and U.S. states) are moving toward cannabis legalization.

And doctors aren’t afraid to call out drug war propaganda when they see it.

Hopefully, ten years from now, we’ll look back at this period as Reefer Madness 2.0. The era when the people demanded legal cannabis and the powers-that-be did everything to prevent it.

But, as the saying goes, facts don’t care about your feelings. No one says you must consume cannabis, so it’s time to stop worrying about what others are doing with their lives.

That means reducing your cannabis stigma. 

Source link

Continue Reading


Copyright © 2021 The Art of MaryJane Media